University of Ioannina
Η προγνωστική σημασία της απόπτωσης στον καρκίνο του μαστού του ανθρώπου
Abstract
dc:descriptionThe aim of this work was to study the apoptosis and the apoptotic index (AI) in ductal breast adenocarcinomas, non specified type (NST) and to correlate the findings with the mitotic index (MI), tumor grade, tumor size, lymph node status, stage, hormone receptors’ status, patients’ age and menopausal status as well as with the immunohistochemical expression of Bcl2 and p53 oncoproteins. Moreover, in this study the correlation of the mitotic index (MI) with the same clinicopathological parameters and the immunohistochemical expression of Bcl2 and p53 oncoproteins was also examined. Finally, the apoptotic index (AI), the mitotic index (MI), the above clinicopathological parameters and the expression of Bcl2 and p53 oncoproteins were correlated with the relapse free survival (RFS) of the patients.In this study, 175 patients with invasive ductal breast adenocarcinomas, non specified type (NST) were included. The follow-up period was approximately 15 years. The follow-up time ranged from 3 months to 191 months, the median follow-up period was 171 months and the mean follow-up period was 125 months. The immunohistochemical expression of Bcl2 and p53 oncoproteins was available in tumor tissue sections of 84 out of 175 patients with the same follow-up period.The estimation of the apoptotic and mitotic indices was based on morphological characteristics in paraffin-embedded tissue sections that stained with hematoxylin and eosin and calculated as the mean number of apoptotic and mitotic cells, respectively, in 20 fields of high magnification (×400).For the statistical analysis, the association of continuous variables was confirmed using the t-test and in case of categorical variables the x2 test was applied. The multivariate analysis of AI was performed using the statistical model of linear regression. RFS was estimated using the Kaplan-Meier method and the multivariate survival analysis was estimated by the Cox model.In this study, a strong statistically significant positive correlation of the apoptotic index (AI) with the mitotic index (MI) (p<0.001), the tumor grade (p<0.001) and the tumor size (p<0.001) was observed. A statistically significant negative correlation of the apoptotic index (AI) with the hormone receptors status was also found (p=0.003). No significant associations of the apoptotic index (AI) with the lymph node involvement, the disease stage, the patients’ age and menopausal status were observed. Similarly, the mitotic index was correlated positively with tumor grade and size and negatively with hormone receptors status. There were no statistical correlations between the mitotic index and lymph node involvement, disease stage, patients’ age and menopausal status.In the present study, the apoptotic and mitotic indices were correlated positively with p53 protein expression (p=0.001 and p=0.008, respectively). An inverse statistically significant association between the apoptotic index and Bcl2 expression was observed (p=0.006). No association was found between the mitotic index and Bcl2 protein expression (p=0.06).Women who presented relapses had higher tumor apoptotic and mitotic indices compared with those without relapses (p=0.001 and p=0.059, respectively). Moreover, women with relapses had tumors of large size (p=0.007) and of high grade (Grade III) (p=0.02). In addition, the majority of relapses were observed in patients with disease stage IIIA.The time or recurrence was shorter (≤ 60 months) for women with high apoptotic and mitotic indices as well as with large tumors (p=0.007).The relapse free survival was longer in patients with small size tumors (p=0.003), absence of lymph node metastases (N0 vs N2: p=0.01, N0 vs N1: p=0.055), stage I (I vs IIB: p=0.01, I vs IIIA: p=0.001) and positive hormone receptors (p=0.04). No significant correlations for the relapse free survival between premenopausal and postmenopausal women as well as between women with positive or negative immunohistochemical expression of Bcl2 and p53 oncoproteins were observed.In this study, the patients with low tumor apoptotic index (AI ≤ 1.8) had longer relapse free survival, therefore, this group of patients may be considered as a group of “good prognosis” compared to the group of patients with high tumor apoptotic index (AI >1.8, p<0.005) – the so called group of “high risk”.The multivariate analysis of the correlations among the apoptotic index and the studied clinicopathological parameters showed that the apoptotic index is a factor that provides important information for relapse free survival. Therefore, it may be used, at least in the sample of patients of the present study, as a prognostic indicator in order to estimate the risk of recurrence in patients with ductal breast adenocarcinomas.Major advantages of this study are the relatively large number of patients that was included and the long follow-up period. The demonstration of an independent value for the apoptotic index allows its use in the clinical practice and provides information for the prediction of survival of patients with breast cancer. In this case, the apoptotic index may serve as an indepented prognostic factor by which the patients with breast cancer could be separated into groups of “high”, “moderate” and “low” risk of recurrence.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsoukalas, Thomas
- Τσουκαλάς, Θωμάς
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17518